- Category: Business
Business
Alcon officially acquires Aerie
Alcon announced Wednesday that it has completed its purchase of Aerie Pharmaceuticals, 3 months following the companies announcing their definite merger agreement.
Business
Alcon officially purchases LumiThera
Acquisition of the Valeda Light Delivery System includes plans to expand commercial market availability in 2026.
Business
Alcon to acquire STAAR Surgical
The $1.5 billion deal includes STAAR’s FDA-approved implantable collamer lenses; expected to close within 6 to 12 months.
Business
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.Business
Alcon to purchase LumiThera
Targeting a Q3 sale, acquisition includes Valeda Light Delivery System, the first and only PBM treatment for early-to-intermediate dry AMD.
Business
Alcon purchases majority stake in Aurion Biotech
Company replaces CEO and founder Greg Kunst, gaining access to groundbreaking CED cell therapy with plans for phase 3 clinical trials expected later this year.
Business
Alcon to acquire Lensar and its next-gen FLACS portfolio
Deal includes the ALLY Robotic Cataract Laser System, the first FDA-cleared platform to enable femtosecond-laser-assisted cataract surgery.
Business
Alcon innovator program identifies contact lens market needs
Inaugural initiative recruits ECPs to collect patient feedback and address top barriers influencing lens wear outcomes.
Business
Alcon officially acquires BELKIN Vision
Purchase involves the Israeli company’s FDA-cleared direct selective laser trabeculoplasty technology.Business
Alcon is buying Belkin Vision and its contact-less SLT glaucoma device
Acquisition is estimated to be worth up to $335 million and will close in Q3 2024.
Business